Africa's first trial of two combination vaccines for HIV has been halted after researchers concluded that the drug was not working. The drug The vaccines as per the Guardian were under testing and subjects included 1,500 people from Uganda, Tanzania and South Africa, aged between 18 and 40.

Trial of groundbreaking HIV vaccine halted in Africa

South Africa will soon start producing an affordable and generic version of the groundbreaking HIV-prevention drug, prophylaxis, long-acting cabotegravir (CAB-LA), for the first time, reported the United Kingdom-based newspaper, The Guardian, on Thursday (May 18).

In a first, South Africa to produce injectable-HIV prevention drug

On a visit to a public hospital in a farming community in November, I saw something that astonished me. Empty beds. Rows of them, their black plastic-covered mattresses stripped of sheets.

In Southern Africa, success against HIV offers hope for beating back another virus

Nagaland is an ideological frontier to the mainland cultural nationalism. The current mainstream nationalism has met its match in a highly evangelized society which today is interchangeable with the Naga identity.

World AIDS Day: Isn't it mainstream enough? Four decades on, still no vaccine for HIV

A clinical trial involving 2,600 young women in sub-Saharan Africa found that Johnson & Johnson's highly anticipated HIV vaccine did not offer adequate protection against the virus, the company told US health officials Tuesday.

Johnson & Johnson's 'Imbokodo' trial for HIV vaccine fails in sub-Saharan Africa

hiv-aids-vaccine

Hiv Aids Vaccine, News on Hiv Aids Vaccine, stories on Hiv Aids Vaccine, articles on Hiv Aids Vaccine, Hiv Aids Vaccine stories at Wion, Hiv Aids Vaccine news, Hiv Aids Vaccine latest news

hiv aids-vaccine

Trial of groundbreaking HIV vaccine halted in Africa

In a first, South Africa to produce injectable-HIV prevention drug

In Southern Africa, success against HIV offers hope for beating back another virus

World AIDS Day: Isn't it mainstream enough? Four decades on, still no vaccine for HIV

Johnson & Johnson's 'Imbokodo' trial for HIV vaccine fails in sub-Saharan Africa